Remove 2025 Remove Clinical Pharmacology Remove Pharmaceutical Companies
article thumbnail

COVID-19 has propelled the regulatory industry years ahead

pharmaphorum

8 It’s encouraging to see this as one of the goals in the EMA’s 2025 Regulatory Sciences Strategy. What remains very clear is that collaboration between sponsor companies, health authorities and other stakeholders will be required to move this forward. Real-time sharing of data. Published 2021 Apr 9. Regulatory science strategy.

Vaccines 143